CO2 Laser Ablation of Lymphangioma Circumscriptum of the Scrotum

Treharne, Linda J.; Murison, Maxwell

doi:10.1089/lrb.2006.4.101

Cited by 21 publications

(14 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Cryotherapy appears rather ineffective, with low remission and high recurrence rates. Several reports have described treatment of LC using CO 2 lasers [1]. However, no previous reports have described LC treated with long-pulsed Nd:YAG lasers, or successful treatment using different lasers for similar lesions.…”

Section: Introductionmentioning

confidence: 99%

Successful Treatment of Congenital Lymphangioma Circumscriptum of the Vulva with CO2 and Long-Pulsed Nd:YAG Lasers

et al. 2014

View full text Add to dashboard Cite

A 16-year-old girl presented with a 9-year history of vesicles on the vulva. She had initially taken a wait-and-see approach, but required treatment because of bleeding. Histological examination of a biopsied vesicle revealed dilated lymph channels in the upper dermis, suggesting lymphangioma circumscriptum (LC). The challenge for this pathology has been to find a conservative treatment with low morbidity and better results than those reported for surgical excision, which has been the mainstay of therapy. In this case, LC of the vulva was successfully treated using a 10,600-nm CO₂ laser and long-pulsed Nd:YAG laser. Use of the 10,600-nm CO₂ laser and long-pulsed Nd:YAG laser appeared effective for treating LC.

show abstract

Section: Introductionmentioning

confidence: 99%

Successful Treatment of Congenital Lymphangioma Circumscriptum of the Vulva with CO2 and Long-Pulsed Nd:YAG Lasers

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Sclerotherapy with different agents such as OKT-432 or Bleomycin have been used successfully for trans-cutaneous injection into lymphangiomas, and also as a pre-operative strategy (Rautio et al, 2003;Baskin et al, 2005). Some authors have proposed approaches with different lasers, such as CO 2 and diode laser therapy (Lapidoth et al, 2006;Treharne and Murison, 2006). For all therapeutic options, the rate of complications has to be carefully taken into account and secondary morbidity has to be avoided.…”

Section: Introductionmentioning

confidence: 99%

Similarities and differences of human and experimental mouse lymphangiomas

Kasten

Schnöink

Bergmann

et al. 2007

Developmental Dynamics

View full text Add to dashboard Cite

Lymphangioma is a disfiguring malformation of early childhood. A mouse lymphangioma model has been established by injecting Freund's incomplete adjuvant (FIA) intraperitoneally, but has not been compared with the human disease. We show that, in accordance with studies from the 1960s, the mouse model represents an oil-granuloma, made up of CD45-positive leukocytes and invaded by blood and lymph vessels. Several markers of lymphatic endothelial cells are expressed in both mouse and human, like CD31, Prox1, podoplanin, and Lyve-1. However, the human disease affects all parts of the lymphovascular tree. We observed convolutes of lymphatic capillaries, irregularly formed collectors with signs of disintegration, and large lymph cysts. We observed VEGFR-2 and -3 expression in both blood vessels and lymphatics of the patients, whereas in mouse VEGFR-2 was confined to activated blood vessels. The experimental mouse FIA model represents a vascularized oil-granuloma rather than a lymphangioma and reflects the complexity of human lymphangioma only partially. Developmental Dynamics 236:2952-2961, 2007.

show abstract

“…Bu tedavi yaklaşımların birçoğundan derin komponentlere ulaşımdaki yetersizliği ve multifokal lezyonlara bağlı yüksek nüks oranları nedeniyle yüz güldürücü sonuçlar alınamamaktadır 3 . LS tedavisinde ablatif ve ablatif olmayan pek çok lazer kullanılmış olup her biri için değişik başarı oranları bildirilmiştir [7][8][9][10][11][12][13][14][15] derindeki yapılarla bağlantılı lenfatik kanalları kapatan karbondioksit lazerden başarılı sonuçlar alınmıştır. Ancak karbondioksit lazer gibi ablatif lazerlerin lokal veya genel anestezi gerektirmesi ve belirgin sikatris bırakması gibi dezavantajları bulunmaktadır 8,9 .…”

Section: Discussionunclassified

“…LS tedavisinde ablatif ve ablatif olmayan pek çok lazer kullanılmış olup her biri için değişik başarı oranları bildirilmiştir [7][8][9][10][11][12][13][14][15] derindeki yapılarla bağlantılı lenfatik kanalları kapatan karbondioksit lazerden başarılı sonuçlar alınmıştır. Ancak karbondioksit lazer gibi ablatif lazerlerin lokal veya genel anestezi gerektirmesi ve belirgin sikatris bırakması gibi dezavantajları bulunmaktadır 8,9 . Vasküler lezyonların tedavisinde kullanılan PDL'ler vasküler dokuların termal gevşeme zamanlarına en uygun atımlar üreten ve bu nedenle de bu amaçla kullanılan lazerler içinde sikatris ya da pigmentasyon bozukluğu oluşturma riski en az olan lazerlerdir.…”

Section: Discussionunclassified

Pulsed dye Lazer Tedavisi Uygulanan Bir Lenfanjioma Sirkumskriptum Olgusu

...

2012

Turkderm

View full text Add to dashboard Cite

ÖzetLenfanjioma sirkumskriptum (LS) genişlemiş dermal lenfatik damarlardan oluşan yüzeyel bir vaskular malformasyondur. Klinik olarak içeriğinde genellikle berrak lenf sıvısı bulunmakla birlikte bazen hemorajiye bağlı olarak kırmızı kan hücrelerini de içeren gruplaşmış translusan veziküller izlenebilir. Vasküler lezyonlarda etkili olduğu bilinen pulsed dye lazer (PDL)'in bu tip hemorajik özellik gösteren lenfanjiomlarda da başarılı olarak kullanılabileceği ileri sürülmüştür. Literatürde PDL tedavisi uygulanan ve lezyonları büyük oranda gerileyen LS'lu iki olgu bildirilmiştir. Burada sol omzunda bazıları hemorajik karakterde kabarcıkları olan ve PDL tedavisine yetersiz kısmi yanıt veren LS'lu 14 yaşında bir kız olgu sunulmaktadır. (Türk derm 2012; 46: 107-9) Anah tar Ke li me ler: Lenfanjioma sirkumskriptum, pulsed dye lazer Sum maryLymphangioma circumscriptum (LS) is a superficial lymphatic malformation which consists of dilated lymphatic channels. Clinically, it presents as grouped translucent vesicles, which usually contain clear lymph fluid but may also contain red blood cells due to hemorrhage. It has been suggested that pulsed dye laser (PDL), which efficacy is known in vascular lesions, has also been successfully used for such lympangiomas with hemorrhagic character. In the literature, two patients who had LS and whose lesions responded well to PDL treatment have been reported. Here, we describe a 14-year-old woman with LS who had vesicles on her left shoulder some of which showed hemorrhagic character and who gave an inadequate partial response to the treatment with PDL. (Turk derm 2012; 46: 107-9

show abstract

CO₂ Laser Ablation of Lymphangioma Circumscriptum of the Scrotum

Cited by 21 publications

References 10 publications

Successful Treatment of Congenital Lymphangioma Circumscriptum of the Vulva with CO<sub>2</sub> and Long-Pulsed Nd:YAG Lasers

Successful Treatment of Congenital Lymphangioma Circumscriptum of the Vulva with CO<sub>2</sub> and Long-Pulsed Nd:YAG Lasers

Similarities and differences of human and experimental mouse lymphangiomas

Pulsed dye Lazer Tedavisi Uygulanan Bir Lenfanjioma Sirkumskriptum Olgusu

Contact Info

Product

Resources

About